Related Experiment Video
Updated: May 5, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy
Christophe Depre1, Qian Wang, Lin Yan
1Department of Cell Biology & Molecular Medicine, UMDNJ, Newark, NJ 07103, USA.
Insights
Chronic pressure overload activates the proteasome system in the heart, which is essential for the development of left ventricular hypertrophy (LVH). This proteasome activation is specific to the subendocardium and required for LVH establishment.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Proteostasis
Background:
- Cardiac adaptation to hemodynamic overload depends on protein turnover.
- Left ventricular hypertrophy (LVH) involves complex molecular adaptations.
- The role of the proteasome system in LVH development was investigated.
Purpose of the Study:
- To determine if chronic LVH activates the proteasome system, particularly in the subendocardium.
- To investigate if the proteasome system is necessary for LVH development.
Main Methods:
- Assessed proteasome subunit gene and protein expression and activity in canine and mouse models of LVH.
- Utilized aortic banding to induce chronic LVH.
- Employed the proteasome inhibitor epoxomicin in a mouse model.
Main Results:
- Proteasome expression and activity significantly increased in the subendocardium of LVH hearts compared to controls.
- These changes were specific to the subendocardium and not observed in other cardiac or peripheral tissues.
- Proteasome inhibition in mice completely prevented LVH development.
Conclusions:
- Increased proteasome expression and activity in the subendocardium are key features of chronic pressure overload.
- The proteasome system is a critical requirement for the development of LVH.
Background:
The adaptation of cardiac mass to hemodynamic overload requires an adaptation of protein turnover, ie, the balance between protein synthesis and degradation. We tested 2 hypotheses: (1) chronic left ventricular hypertrophy (LVH) activates the proteasome system of protein degradation, especially in the myocardium submitted to the highest wall stress, ie, the subendocardium, and (2) the proteasome system is required for the development of LVH.
Methods And Results:
Gene and protein expression of proteasome subunits and proteasome activity were measured separately from left ventricular subendocardium and subepicardium, right ventricle, and peripheral tissues in a canine model of severe, chronic (2 years) LVH induced by aortic banding and then were compared with controls. Both gene and protein expressions of proteasome subunits were increased in LVH versus control (P<0.05), which was accompanied by a significant (P<0.05) increase in proteasome activity. Posttranslational modification of the proteasome was also detected by 2-dimensional gel electrophoresis. These changes were found specifically in left ventricular subendocardium but not in left ventricular subepicardium, right ventricle, or noncardiac tissues from the same animals. In a mouse model of chronic pressure overload, a 50% increase in heart mass and a 2-fold increase in proteasome activity (both P<0.05 versus sham) were induced. In that model, the proteasome inhibitor epoxomicin completely prevented LVH while blocking proteasome activation.
Conclusions:
The increase in proteasome expression and activity found during chronic pressure overload in myocardium submitted to higher stress is also required for the establishment of LVH.
Related Concept Videos
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cellular Adaptation II: Hypertrophy

